Covered recipient · General Payments record
MARK ALLEN ERDMAN
Podiatric Medicine & Surgery Service Providers Podiatrist
General Payments · PY2018–2024
$2,989.49
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $528.06 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $234.31 | 6 |
| Kerecis Limited | $180.61 | 2 |
| BIOCOMPOSITES INC | $33.56 | 1 |
| ConvaTec Inc. | $21.49 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $21.29 | 1 |
| Anika Therapeutics, Inc. | $21.12 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $25.03 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570709 | CMS |
| Amgen Inc. | $19.46 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570705 | CMS |
| Amgen Inc. | $124.98 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570707 | CMS |
| Amgen Inc. | $6.11 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570711 | CMS |
| Amgen Inc. | $30.80 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570713 | CMS |
| Amgen Inc. | $27.93 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111570715 | CMS |
| Anika Therapeutics, Inc. | $21.12 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136024483 | CMS |
| BIOCOMPOSITES INC | $33.56 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146434390 | CMS |
| Boston Scientific Corporation | $21.29 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092344820 | CMS |
| ConvaTec Inc. | $21.49 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373528 | CMS |
| Kerecis Limited | $159.70 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120096795 | CMS |
| Kerecis Limited | $20.91 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120110799 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $15.68 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105913744 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.